On 30 November, Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) shares advanced 0.46% and was closed at $67.90. QIHU EPS growth in last 5 year was 179.00%. Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) year to date (YTD) performance is 18.58%.
On 25 November, Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) announced that its joint venture Oriental Shiny Star Limited (“JVC”) has entered into a license agreement with Smilegate Entertainment, Inc. (“SG”), a leading Korean game developer, to publish and operate Cross Fire 2 for a five-year term in mainland China on an exclusive basis.
Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) shares advanced 3.91% in last trading session and ended the day at $3.72. AMPE Gross Margin is 85.70% and its has a return on assets of -51.60%. Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) quarterly performance is 26.53%.
Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) announced it has established a record date of December 1, 2015 for its previously announced distribution to its stockholders of its shares of Common Stock of Aytu BioSciences, Inc. Ampio will distribute one (1) share of Aytu common stock for every five (5) shares of Ampio Common Stock owned as of the record date. This distribution will constitute over 70% of the Aytu shares outstanding at this time and approximately 90% of the Aytu shares owned by Ampio. The distribution date is expected to be January 4, 2016.
Groupon, Inc. (NASDAQ:GRPN) caters to the Technology space. It has a net profit margin of 2.40% and weekly performance is 6.25%. On the last day of trading company shares ended up at $2.89. Groupon, Inc. (NASDAQ:GRPN) distance from 50-day simple moving average (SMA50) is 18.18%.
On 23 November, Groupon, Inc. (NASDAQ:GRPN) said that, Consumers and business owners should want Groupon to succeed because its model still offers unique benefits.
Radius Health, Inc. (NASDAQ:RDUS) shares decreased -7.03% in last trading session and ended the day at $60.81. RDUS has a return on assets of -31.70%. Radius Health, Inc. (NASDAQ:RDUS) quarterly performance is -0.08%.
On 18 November, Radius Health, Inc. (NASDAQ:RDUS) delayed a drug submission to U.S. regulators to avoid rushing its filing and to respect employees’ holiday plans, Chief Executive Officer Robert Ward said.
Pulaski Financial Corporation (NASDAQ:PULB) caters to the Financial space. It has a net profit margin of 28.10% and weekly performance is 4.59%. On the last day of trading company shares ended up at $16.41. Pulaski Financial Corporation (NASDAQ:PULB) distance from 50-day simple moving average (SMA50) is -3.23%.
Zacks cut shares of Pulaski Financial Corporation (NASDAQ:PULB) from a hold rating to a sell rating in a research report released on Sunday, ARN reports.
Leave a Reply